Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON26648Withdrawn
Open-label, single-arm trial of tamoxifen and z-endoxifen in breast cancer, sponsored by Slotervaartziekenhuis. Planned start Nov 2012; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON26648.